1492 Capital Management LLC Arcutis Biotherapeutics, Inc. Transaction History

1492 Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$7.51 - $15.0 $5,624 - $11,235	-749 Reduced 0.34%	222,767 $2.12 Million
Q1 2023 May 12, 2023	BUY	$10.23 - $17.14 $500,963 - $839,345	48,970 Added 28.06%	223,516 $2.46 Million
Q4 2022 Feb 13, 2023	SELL	$13.96 - $20.4 $52,685 - $76,989	-3,774 Reduced 2.12%	174,546 $2.58 Million
Q3 2022 Nov 10, 2022	BUY	$17.85 - $26.95 $6,443 - $9,728	361 Added 0.2%	178,320 $3.41 Million
Q2 2022 Aug 10, 2022	BUY	$16.33 - $22.2 $1.68 Million - $2.28 Million	102,767 Added 136.67%	177,959 $3.79 Million
Q1 2022 May 12, 2022	BUY	$14.38 - $22.79 $1.08 Million - $1.71 Million	75,192 New	75,192 $1.45 Million

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $825M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.